Clinical Trial Update: Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating TLN-4601 in patients with recurring glioblastoma multiforme was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• TLN-4601

Snippet

Sponsor: Thallion Pharmaceuticals | Conditions: Glioblastoma Multiforme | Phase 2 | Status: TERMINATED